NeueHealth, Inc.
NEUE
$6.51
$0.01830.28%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 300.38M | 281.17M | 260.93M | 257.73M | 246.32M |
| Total Other Revenue | 590.06M | 626.18M | 675.73M | 739.16M | 787.04M |
| Total Revenue | 890.44M | 907.35M | 936.66M | 996.89M | 1.03B |
| Cost of Revenue | 674.89M | 706.16M | 742.14M | 822.11M | 865.86M |
| Gross Profit | 215.55M | 201.19M | 194.52M | 174.78M | 167.50M |
| SG&A Expenses | 227.20M | 252.81M | 270.90M | 270.80M | 301.68M |
| Depreciation & Amortization | 14.22M | 14.64M | 15.65M | 16.07M | 16.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 916.31M | 973.61M | 1.03B | 1.11B | 1.18B |
| Operating Income | -25.87M | -66.26M | -92.02M | -112.09M | -150.86M |
| Income Before Tax | -60.88M | -107.14M | -99.46M | -117.55M | -577.02M |
| Income Tax Expenses | 2.21M | 2.05M | 2.60M | 4.86M | -1.32M |
| Earnings from Continuing Operations | -63.09 | -109.18 | -102.06 | -122.41 | -575.70 |
| Earnings from Discontinued Operations | 12.85M | 2.80M | 2.34M | -440.41M | -493.89M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -31.69M | -24.12M | -34.96M | 201.14M | 131.44M |
| Net Income | -81.93M | -130.51M | -134.68M | -361.67M | -938.16M |
| EBIT | -25.87M | -66.26M | -92.02M | -112.09M | -150.86M |
| EBITDA | -11.65M | -51.62M | -76.38M | -90.16M | -128.31M |
| EPS Basic | -15.97 | -22.00 | -22.63 | -51.16 | -123.67 |
| Normalized Basic EPS | -8.10 | -9.86 | -12.97 | 14.89 | 1.87 |
| EPS Diluted | -15.97 | -22.00 | -22.63 | -51.16 | -123.67 |
| Normalized Diluted EPS | -8.10 | -9.86 | -12.97 | 14.89 | 1.87 |
| Average Basic Shares Outstanding | 34.06M | 33.33M | 32.84M | 32.57M | 32.26M |
| Average Diluted Shares Outstanding | 34.06M | 33.33M | 32.84M | 32.57M | 32.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |